These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7515330)

  • 1. Regulation of experimental autoimmune neuritis by transforming growth factor-beta 1.
    Gregorian SK; Lee WP; Beck LS; Rostami A; Amento EP
    Cell Immunol; 1994 Jun; 156(1):102-12. PubMed ID: 7515330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis.
    Gregorian SK; Clark L; Heber-Katz E; Amento EP; Rostami A
    Cell Immunol; 1993 Sep; 150(2):298-310. PubMed ID: 7690307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.
    Jung S; Schluesener HJ; Schmidt B; Fontana A; Toyka KV; Hartung HP
    Immunology; 1994 Dec; 83(4):545-51. PubMed ID: 7533133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed-type hypersensitivity response in experimental autoimmune neuritis treated with peptide-coupled spleen cells.
    Gregorian SK; Rostami A
    J Neuroimmunol; 1994 Apr; 51(1):69-75. PubMed ID: 7512578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
    Jung S; Gaupp S; Korn T; Köllner G; Hartung HP; Toyka KV
    J Neurosci Res; 2004 Feb; 75(4):524-35. PubMed ID: 14743436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of experimental allergic neuritis in the BN rat: P2 protein-specific T cells overcome resistance to actively induced disease.
    Linington C; Mann A; Izumo S; Uyemura K; Suzuki M; Meyermann R; Wekerle H
    J Immunol; 1986 Dec; 137(12):3826-31. PubMed ID: 2431045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role.
    Pelidou SH; Zou LP; Deretzi G; Oniding C; Mix E; Zhu J
    Exp Neurol; 2000 May; 163(1):165-72. PubMed ID: 10785455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis.
    Kiefer R; Gold R; Gehrmann J; Lindholm D; Wekerle H; Kreutzberg GW
    J Neurosci Res; 1993 Nov; 36(4):391-8. PubMed ID: 7505838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells.
    Issazadeh S; Mustafa M; Ljungdahl A; Höjeberg B; Dagerlind A; Elde R; Olsson T
    J Neurosci Res; 1995 Apr; 40(5):579-90. PubMed ID: 7602612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
    Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
    Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta.
    Jung S; Krämer S; Schluesener HJ; Hünig T; Toyka K; Hartung HP
    J Immunol; 1992 Jun; 148(12):3768-75. PubMed ID: 1376340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of associated cell-mediated immune mechanisms in experimental autoimmune neuritis rats.
    Yun W; Hua-bing W; Wei-zhi W
    J Neuroimmunol; 2007 Apr; 185(1-2):87-94. PubMed ID: 17346805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Ljungdahl A; Höjeberg B; Link J; He B; Qiao J; Melms A; Olsson T
    Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A complementary peptide vaccine that induces T cell anergy and prevents experimental allergic neuritis in Lewis rats.
    Araga S; Kishimoto M; Doi S; Nakashima K
    J Immunol; 1999 Jul; 163(1):476-82. PubMed ID: 10384151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic study on experimental allergic neuritis mediated by T cell line specific for bovine P2 protein in Lewis rats.
    Izumo S; Linington C; Wekerle H; Meyermann R
    Lab Invest; 1985 Aug; 53(2):209-18. PubMed ID: 2410663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope and functional specificity of peripheral tolerance induction in experimental autoimmune encephalomyelitis in adult Lewis rats.
    Malotky MK; Pope L; Miller SD
    J Immunol; 1994 Jul; 153(2):841-51. PubMed ID: 7517425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of autoimmune neuritis in IFN-gamma receptor-deficient mice.
    Zhu Y; Ljunggren HG; Mix E; Li HL; van der Meide P; Elhassan AM; Winblad B; Zhu J
    Exp Neurol; 2001 Jun; 169(2):472-8. PubMed ID: 11358460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cytokine autoantibodies in experimental autoimmune neuritis in Lewis rats.
    Zhu W; Mix E; Nennesmo I; Adem A; Zhu J
    Exp Neurol; 2004 Dec; 190(2):486-94. PubMed ID: 15530887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of stilbene-type anion channel blockers on the immune response during experimental allergic neuritis (EAN).
    Mix E; Correale J; Olsson T; Solders G; Link H
    Immunopharmacol Immunotoxicol; 1992; 14(3):579-609. PubMed ID: 1381387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo.
    Linington C; Izumo S; Suzuki M; Uyemura K; Meyermann R; Wekerle H
    J Immunol; 1984 Oct; 133(4):1946-50. PubMed ID: 6206142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.